A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancer
published in: International Journal of Gynecological Cancer
date of publication: 2007-03-05
main subject: fallopian tube, bevacizumab, fallopian tube cancer, paclitaxel, carboplatin, fallopian tube carcinoma
Cites articles
There is nothing here
Article - wd:Q33374458